Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Suspension: 205 mg/45 mg per 5 mL, 250 mg per 5 mL
- Tablet: 820 mg/180 mg
Registered products in the Philippines
3 products registered with the Food and Drug Administration (FDA) Philippines list Cotrimazine as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
All registered products3
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
NoneCotrimazine | 250 mg per 5 mL SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | Drugmaker’s Laboratories Inc.Philippines | — | DR-XY22319 | Jun 13, 2028 | |
TrizineCotrimazine | 205 mg/45 mg per 5 mL SuspensionAmber Bottle x 60 mL | Rx | Swiss Pharma Research Laboratories, Inc.Philippines | Trader: Phoenix Pharmaceuticals, Inc. | DR-XY21983 | Oct 2, 2029 | |
Trizine ForteCotrimazine | 820mg/180mg TabletAluminum Foil Strip x 4's (Box of 48's) | Rx | Swisspharma Research Laboratories, Inc.Philippines | Trader: Phoenix Pharmaceutical, Inc. | DR-XY24055 | Apr 2, 2028 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Formulary and pricing (Philippines)
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .